The lymphocyte-monocyte ratio in clinical practice

We read the article ‘Pretreatment lymphocyte-monocyte ratio (LMR) as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma’ by Hutterer et al .1 They aimed to investigate the potential prognostic impact of the LMR in a large European cohort of patients with localised upper urinary tract urothelial carcinoma. They concluded that LMR might be considered an additional prognostic factor in upper urinary tract urothelial carcinoma in the future. A complete blood count is an easy examination technique that gives us information about the patients’ formed …